First Eagle Investment Management LLC cut its holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 50.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,081 shares of the company’s stock after selling 104,551 shares during the period. […]

Related Keywords

Canada , United States , Pacira Biosciences , Exchange Commission , Jpmorgan Chase Co , Barclays , Gradient Investments , National Bank , Securities Exchange Commission , Nasdaq , Needham Company , Gotham Asset Management , Pacira Biosciences Inc , First Eagle Investment Management , Free Report , Eagle Investment Management , Asset Management , Director Gary , Biosciences Trading Down , Get Free Report , Visit Holdingschannel , Pacira Biosciences Daily ,